Buhat, Shynthal P.

HRN: 06-61-07  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2025
CEFUROXIME 500MG (TAB)
08/10/2025
08/16/2025
ORAL
500mg
Q12
Thinly MSAF
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: